Technical Analysis for ONCS - OncoSec Medical Incorporated

Grade Last Price % Change Price Change
grade F 1.84 -2.13% -0.04
ONCS closed down 2.13 percent on Friday, August 23, 2019, on 12 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ONCS trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -2.13%
Narrow Range Bar Range Contraction -2.13%
Lower Bollinger Band Walk Weakness -2.13%

Older signals for ONCS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
OncoSec Medical Incorporated, a hybrid device and gene therapy biotechnology company, designs, develops, and commercializes medical approaches principally immunotherapy for the treatment of solid tumors in the United States. Its clinical programs include three Phase II clinical trials to assess the ImmunoPulse technology in patients with melanoma, Merkel cell carcinoma, and cutaneous T-cell lymphoma. It has a collaboration agreement with Heat Biologics, Inc. to evaluate the combination of immunotherapy platforms. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated is headquartered in San Diego, California.
Medicine Biotechnology Biology Solid Tumors Immunotherapy Cancer Treatments Gene Therapy Virotherapy Melanoma Genetic Engineering Cutaneous T Cell Lymphoma Heat Biologics Merkel Cell Carcinoma
Is ONCS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 19.6
52 Week Low 1.8
Average Volume 110,797
200-Day Moving Average 5.1622
50-Day Moving Average 2.3002
20-Day Moving Average 2.068
10-Day Moving Average 2.006
Average True Range 0.1697
ADX 19.04
+DI 13.9675
-DI 28.2955
Chandelier Exit (Long, 3 ATRs ) 1.8809
Chandelier Exit (Short, 3 ATRs ) 2.3091
Upper Bollinger Band 2.3056
Lower Bollinger Band 1.8304
Percent B (%b) 0.02
BandWidth 22.978723
MACD Line -0.1291
MACD Signal Line -0.1213
MACD Histogram -0.0079
Fundamentals Value
Market Cap 38.95 Million
Num Shares 21.2 Million
EPS -1.14
Price-to-Earnings (P/E) Ratio -1.61
Price-to-Sales 0.00
Price-to-Book 1.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.98
Resistance 3 (R3) 1.98 1.94 1.95
Resistance 2 (R2) 1.94 1.91 1.94 1.94
Resistance 1 (R1) 1.89 1.88 1.87 1.89 1.94
Pivot Point 1.85 1.85 1.84 1.85 1.85
Support 1 (S1) 1.80 1.82 1.78 1.80 1.74
Support 2 (S2) 1.76 1.79 1.76 1.74
Support 3 (S3) 1.71 1.76 1.73
Support 4 (S4) 1.71